Roundup Lawsuit Costs Continue To Pile Up, With $16 Billion Set Aside to Resolve Non-Hodgkin Lymphoma Claims
Bayer's stock value has plummeted 70% since it purchased Monsanto, and CEO now indicates Roundup lawsuits pose serious threat to future of company